Shangri-La Tibetan Pharmaceuticals, Inc. - FORM S-1 - EX-10.10 - EXHIBIT 10.10 - May 14, 2010

Attached files

file filename
S-1 - FORM S-1 - Shangri-La Tibetan Pharmaceuticals, Inc.ds1.htm
EX-5.2 - EXHIBIT 5.2 - Shangri-La Tibetan Pharmaceuticals, Inc.dex52.htm
EX-1.1 - EXHIBIT 1.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex11.htm
EX-5.1 - EXHIBIT 5.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex51.htm
EX-3.I.2 - EXHIBIT 3(I)(2) - Shangri-La Tibetan Pharmaceuticals, Inc.dex3i2.htm
EX-21.1 - EXHIBIT 21.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex211.htm
EX-23.1 - EXHIBIT 23.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex231.htm
EX-10.1 - EXHIBIT 10.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex101.htm
EX-10.2 - EXHIBIT 10.2 - Shangri-La Tibetan Pharmaceuticals, Inc.dex102.htm
EX-10.6 - EXHIBIT 10.6 - Shangri-La Tibetan Pharmaceuticals, Inc.dex106.htm
EX-10.3 - EXHIBIT 10.3 - Shangri-La Tibetan Pharmaceuticals, Inc.dex103.htm
EX-10.9 - EXHIBIT 10.9 - Shangri-La Tibetan Pharmaceuticals, Inc.dex109.htm
EX-10.8 - EXHIBIT 10.8 - Shangri-La Tibetan Pharmaceuticals, Inc.dex108.htm
EX-10.5 - EXHIBIT 10.5 - Shangri-La Tibetan Pharmaceuticals, Inc.dex105.htm
EX-99.2 - EXHIBIT 99.2 - Shangri-La Tibetan Pharmaceuticals, Inc.dex992.htm
EX-3.I.1 - EXHIBIT 3(I)(1) - Shangri-La Tibetan Pharmaceuticals, Inc.dex3i1.htm
EX-99.1 - EXHIBIT 99.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex991.htm
EX-10.7 - EXHIBIT 10.7 - Shangri-La Tibetan Pharmaceuticals, Inc.dex107.htm
EX-10.4 - EXHIBIT 10.4 - Shangri-La Tibetan Pharmaceuticals, Inc.dex104.htm
EX-10.15 - EXHIBIT 10.15 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1015.htm
EX-10.16 - EXHIBIT 10.16 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1016.htm
EX-10.14 - EXHIBIT 10.14 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1014.htm
EX-10.17 - EXHIBIT 10.17 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1017.htm
EX-10.18 - EXHIBIT 10.18 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1018.htm
EX-10.12 - EXHIBIT 10.12 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1012.htm
EX-3.II.2 - EXHIBIT 3(II)(2) - Shangri-La Tibetan Pharmaceuticals, Inc.dex3ii2.htm
EX-10.19 - EXHIBIT 10.19 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1019.htm
EX-10.13 - EXHIBIT 10.13 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1013.htm
EX-3.II.1 - EXHIBIT 3(II)(1) - Shangri-La Tibetan Pharmaceuticals, Inc.dex3ii1.htm
EX-10.11 - EXHIBIT 10.11 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1011.htm

Exhibit 10.10

Translation of Medicinal Material Procurement Contract

Party A (Purchaser): Yunnan Shangri-La Tibetan Pharmaceutical Group Limited

Party B (Supplier): Cili Peichu

 

Product’s Name

    Spec    Unit    Quantity    Unit
Price		    Value
(RMB)		    Procurement
Period		    Memo

Chinese cinnamon

       kg    13968    39.98    544,482.10    09.1.1-12.31   

Xiaobopi San

       kg    2250    101.98    227,658.51    09.1.1-12.31   

Rhizoma Kaempferiae

       kg    3189    41.10    131,057.67    09.1.1-12.31   

Radix Et Rhizoma Rubiae

       kg    5303    113.17    600,153,10    09.1.1-12.31   

Marvel of Peru

       kg    21195    37.26    789,737.00    09.1.1-12.31   

Radix Onosmatis

       kg    5145    258.43    1,329,561.11    09.1.1-12.31   

Niter

       kg    2230    61.57    137,289.20    09.1.1-12.31   

The Aggregate Value: RMB 3,759,938.68

The Procurement Place: Yunnan Shangri-La Tibetan Medicine Group Co., Ltd.

Date of Delivery: Delivery within 20 days upon the signature of the Contract

Payment Method: Party A shall make payment of all the accounts payable within 10 days upon the entry of products in the warehouse and Party B shall draw the accounts receivable by presentation of the warehouse voucher.

Quality Standard: State Standard

Package: Polypropylene (PP) Knitted Bag or cloth bag free of any damage.

Quality Requirements by Party B: The products shall comply with the state quality standards as well as the agreed quality standard bases on the said quality standards; Packing Sound

Quality Requirements agreed by Both Parties: The Tibetan medicinal materials standard under the administration authorities of the Ministry of Public Health shall be executed.

Liability of Breach: The breached party shall make the compensation for the non-breach party by the amount equivalent to 30% of the aggregate value of the contract herein.

This contract is in duplicate and shall be effective upon both parties’ signature, seal, and putting one’s fingerprint.

Party A: Yunnan Shangri-La Tibetan Pharmaceutical Group Limited

Authorized Representative: Hong Yu (Signature)

Yunnan Shangri-La Tibetan Pharmaceutical Group Limited (Seal)

Signature Date: Jan 5, 2009

Party B: Cili Peichu

Authorized Representative: Cili Peichu (Signature)

Signature Date: Jan 5, 2009

Shangri-La Tibetan Pharmaceuticals, Inc. Reports